STAT3 activates the transcription of lncRNA NR2F1‐AS1 to promote progression of melanoma via regulating miR‐493‐5p/GOLM1 axis

作者: Qing Xu , Xiong Wang , Mei Bai , Yan-Li Huang , Zong-Zhou Wu

DOI: 10.1002/JGM.3338

关键词: Antisense RNABiologyCancer researchMelanomaCell growthGene knockdownCarcinogenesisTranscription (biology)Chromatin immunoprecipitationMelanoma Biomarker

摘要: BACKGROUND Long non-coding RNAs (lncRNAs) are vital regulators during the biological processes of melanoma. The present study aimed to uncover functions lncRNA termed NR2F1 antisense RNA 1 (NR2F1-AS1) in melanoma and potential mechanisms. METHODS Relative levels NR2F1-AS1 miR-493-5p a total 137 paired primary tissues corresponding non-tumor tissues, as well three cell lines, were examined by real-time polymerase chain reaction. clinical significance expression was analyzed statistically. STAT3 binding motif promoter region identified JASPAR (http://jaspar.genereg.net). association between determined dual-luciferase reporter chromatin immunoprecipitation assays. effects on proliferation, migration measured counting kit-8 (CCK-8), Edu, transwell wound healing Dual-luciferase pull-down assays applied validate interaction among NR2F1-AS1, GOLM1. Furthermore, vivo experiments conducted demonstrate oncogenic role RESULTS Up-regulated down-regulated detected tumors cells. overexpression induced STAT3. High correlated advanced tumor stage poor prognosis Functional studies using CCK-8, revealed that proliferative, migratory invasive capacities cells attenuated inhibition NR2F1-AS1. Moreover, able up-regulate GOLM1 through recognizing miR-493-5p. knockdown distinctly reversed these inhibitory down-regulation tumorigenesis progression CONCLUSIONS Our findings key for via targeting miR-493-5p/GOLM1 axis.

参考文章(31)
Debina Sarkar, Euphemia Y Leung, Bruce C Baguley, Graeme J Finlay, Marjan E Askarian-Amiri, Epigenetic regulation in human melanoma: past and future Epigenetics. ,vol. 10, pp. 103- 121 ,(2015) , 10.1080/15592294.2014.1003746
Leonardo Salmena, Laura Poliseno, Yvonne Tay, Lev Kats, Pier Paolo Pandolfi, A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? Cell. ,vol. 146, pp. 353- 358 ,(2011) , 10.1016/J.CELL.2011.07.014
M. Maio, Melanoma as a model tumour for immuno-oncology Annals of Oncology. ,vol. 23, ,(2012) , 10.1093/ANNONC/MDS257
Morgane Vourc'h-Jourdain, Ludovic Martin, Sébastien Barbarot, Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review. Journal of The American Academy of Dermatology. ,vol. 68, pp. 493- 498 ,(2013) , 10.1016/J.JAAD.2012.09.039
Xiaolong Qi, Da-Hong Zhang, Nan Wu, Jun-Hua Xiao, Xiang Wang, Wang Ma, ceRNA in cancer: possible functions and clinical implications Journal of Medical Genetics. ,vol. 52, pp. 710- 718 ,(2015) , 10.1136/JMEDGENET-2015-103334
Adam M. Schmitt, Howard Y. Chang, Long Noncoding RNAs in Cancer Pathways Cancer Cell. ,vol. 29, pp. 452- 463 ,(2016) , 10.1016/J.CCELL.2016.03.010
Masayuki Matsui, David R. Corey, Non-coding RNAs as drug targets Nature Reviews Drug Discovery. ,vol. 16, pp. 167- 179 ,(2017) , 10.1038/NRD.2016.117
Julia Beermann, Maria-Teresa Piccoli, Janika Viereck, Thomas Thum, Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches Physiological Reviews. ,vol. 96, pp. 1297- 1325 ,(2016) , 10.1152/PHYSREV.00041.2015
Qing-Hai Ye, Wen-Wei Zhu, Ju-Bo Zhang, Yi Qin, Ming Lu, Guo-Ling Lin, Lei Guo, Bo Zhang, Zhen-Hai Lin, Stephanie Roessler, Marshonna Forgues, Hu-Liang Jia, Lu Lu, Xiao-Fei Zhang, Bao-Feng Lian, Lu Xie, Qiong-Zhu Dong, Zhao-You Tang, Xin Wei Wang, Lun-Xiu Qin, GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis Cancer Cell. ,vol. 30, pp. 444- 458 ,(2016) , 10.1016/J.CCELL.2016.07.017
Mohan M. Kumar, Ravi Goyal, LncRNA as a Therapeutic Target for Angiogenesis. Current Topics in Medicinal Chemistry. ,vol. 17, pp. 1750- 1757 ,(2017) , 10.2174/1568026617666161116144744